Natixis Advisors, L.P. Boston Scientific Corp Transaction History

Natixis Advisors, L.P.

$51.3 Billion
Q3 2024

A detailed history of Natixis Advisors, L.P. transactions in Boston Scientific Corp stock. As of the latest transaction made, Natixis Advisors, L.P. holds 1,845,805 shares of BSX stock, worth $167 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

1,845,805

Previous 1,749,354 5.51%

Holding current value

$167 Million

Previous $135 Million 14.82%

% of portfolio

0.3%

Previous 0.29%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$72.96 - $84.0 $7.04 Million - $8.1 Million	96,451 Added 5.51%	1,845,805 $155 Million
Q2 2024 Aug 01, 2024	BUY	$67.33 - $77.71 $4.31 Million - $4.98 Million	64,068 Added 3.8%	1,749,354 $135 Million
Q1 2024 Apr 25, 2024	SELL	$57.6 - $68.62 $1.9 Million - $2.26 Million	-32,901 Reduced 1.91%	1,685,286 $115 Million
Q4 2023 Feb 06, 2024	SELL	$48.64 - $57.81 $2.78 Million - $3.31 Million	-57,240 Reduced 3.22%	1,718,187 $99.3 Million
Q3 2023 Nov 13, 2023	BUY	$50.19 - $54.68 $45.3 Million - $49.3 Million	902,424 Added 103.37%	1,775,427 $93.7 Million
Q2 2023 Aug 15, 2023	SELL	$49.72 - $54.64 $7.91 Million - $8.69 Million	-159,008 Reduced 15.41%	873,003 $47.2 Million
Q1 2023 May 11, 2023	SELL	$45.09 - $50.03 $79,854 - $88,603	-1,771 Reduced 0.17%	1,032,011 $51.6 Million
Q4 2022 Jan 27, 2023	BUY	$39.56 - $47.22 $7.15 Million - $8.53 Million	180,729 Added 21.19%	1,033,782 $47.8 Million
Q3 2022 Nov 14, 2022	BUY	$36.71 - $109.66 $9.89 Million - $29.5 Million	269,361 Added 46.15%	853,053 $33 Million
Q2 2022 Aug 12, 2022	SELL	$35.24 - $47.1 $2.14 Million - $2.86 Million	-60,738 Reduced 9.43%	583,692 $21.8 Million
Q1 2022 May 12, 2022	BUY	$40.9 - $45.1 $2.03 Million - $2.23 Million	49,523 Added 8.32%	644,430 $28.5 Million
Q4 2021 Feb 08, 2022	BUY	$38.07 - $44.87 $505,265 - $595,514	13,272 Added 2.28%	594,907 $25.3 Million
Q3 2021 Nov 15, 2021	SELL	$41.23 - $45.88 $900,174 - $1 Million	-21,833 Reduced 3.62%	581,635 $25.2 Million
Q2 2021 Aug 12, 2021	BUY	$38.58 - $44.24 $948,605 - $1.09 Million	24,588 Added 4.25%	603,468 $25.8 Million
Q1 2021 May 05, 2021	BUY	$35.27 - $39.67 $1.57 Million - $1.77 Million	44,594 Added 8.35%	578,880 $22.4 Million
Q4 2020 Feb 12, 2021	BUY	$33.15 - $41.97 $1.59 Million - $2.02 Million	48,028 Added 9.88%	534,286 $19.2 Million
Q3 2020 Nov 12, 2020	BUY	$34.44 - $42.23 $864,409 - $1.06 Million	25,099 Added 5.44%	486,258 $18.6 Million
Q2 2020 Aug 11, 2020	BUY	$30.19 - $39.11 $2.3 Million - $2.97 Million	76,047 Added 19.75%	461,159 $16.2 Million
Q1 2020 Apr 27, 2020	BUY	$25.83 - $45.71 $4.83 Million - $8.55 Million	187,067 Added 94.46%	385,112 $12.6 Million
Q4 2019 Feb 10, 2020	BUY	$37.87 - $45.37 $657,612 - $787,850	17,365 Added 9.61%	198,045 $8.96 Million
Q3 2019 Nov 12, 2019	BUY	$40.31 - $43.45 $1.57 Million - $1.69 Million	38,832 Added 27.38%	180,680 $7.35 Million
Q2 2019 Aug 12, 2019	BUY	$34.91 - $42.98 $402,512 - $495,559	11,530 Added 8.85%	141,848 $6.1 Million
Q1 2019 May 15, 2019	SELL	$32.91 - $40.75 $220,398 - $272,902	-6,697 Reduced 4.89%	130,318 $5 Million
Q4 2018 Feb 13, 2019	BUY	$31.73 - $39.04 $82,910 - $102,011	2,613 Added 1.94%	137,015 $4.84 Million
Q3 2018 Nov 13, 2018	SELL	$32.83 - $38.63 $284,012 - $334,188	-8,651 Reduced 6.05%	134,402 $5.17 Million
Q2 2018 Aug 14, 2018	SELL	$26.84 - $34.32 $63,208 - $80,823	-2,355 Reduced 1.62%	143,053 $0
Q1 2018 May 10, 2018	BUY	$25.2 - $28.54 $691,034 - $782,623	27,422 Added 23.24%	145,408 $3.97 Million
Q4 2017 Feb 14, 2018	BUY	$24.79 - $29.8 $1.76 Million - $2.12 Million	71,031 Added 151.27%	117,986 $2.92 Million
Q3 2017 Nov 14, 2017	BUY	$26.26 - $29.17 $1.23 Million - $1.37 Million	46,955	46,955 $1.37 Million

Others Institutions Holding BSX

# of Institutions

1,543

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $130B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.

Account

Natixis Advisors, L.P. Boston Scientific Corp Transaction History